bioRxivMicrobiologyPreprint
Evaluation of the antiviral effect of chlorine dioxide (ClO2) using a vertebrate model inoculated with avian coronavirus
X. Zambrano-Estrada, C. A. Dominguez-Sanchez, M. Banuet-Martinez, F. Guerrero-de la Rosa, T. Garcia-Gasca, L. Prieto-Valiente, K. Acevedo-Whitehouse
Abstract
BackgroundThe need for safe and effective antiviral treatments is pressing given the number of viral infections that are prevalent in animal and human populations, often causing devastating economic losses and mortality. Informal accounts of anecdotal use of chlorine dioxide (ClO2), a well-known disinfectant and antiseptic, in COVID-19 patients has raised concern about potential toxicity, but also raises the question that ClO2 might elicit antiviral effects, a possibility that has never been examined in vivo in any animal model. Here, we challenged the hypothesis that ClO2 decreases the viral load and virus-induced mortality in a vertebrate model. For this, we determined viral load, virus-induced lesions and mortality in 10-day old chick embryos inoculated with 104 mean EID50/mL of attenuated Massachusetts and Connecticut avian coronavirus (IBV) strains. ResultsThe ClO2 treatment had a marked impact on IBV infection. Namely, viral titres were 2.4-fold lower and mortality was reduced by half in infected embryos that were treated with ClO2. Infection led to developmental abnormalities regardless of treatment. Lesions typical of IBV infections were observed in all inoculated embryos, but severity tended to be significantly lower in ClO2-treated embryos. We found no gross or microscopic evidence of toxicity caused by ClO2 at the doses used herein. ConclusionsOur study shows that ClO2 could be a safe and viable way of treating and mitigating the effects of avian coronavirus infections, and raises the possibility that similar effects could be observed in other organisms. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=79 SRC="FIGDIR/small/336768v3_ufig1.gif" ALT="Figure 1"> View larger version (17K): org.highwire.dtl.DTLVardef@7eb076org.highwire.dtl.DTLVardef@1733722org.highwire.dtl.DTLVardef@128ad69org.highwire.dtl.DTLVardef@19108b0_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: chicken / avian
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Nanodroplet-Benzalkonium Chloride Formulation Demonstrates In Vitro and Ex Vivo Broad-Spectrum Antiviral Activity Against SARS-CoV-2 and Other Enveloped Viruses
J. Pannu, S. Ciotti, … A. I. Fattom·bioRxiv·Nov 12, 2020
- In Vitro Efficacy of "Essential Iodine Drops" Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2)
Z. Kontos·bioRxiv·Nov 7, 2020
- Low ozone concentration and negative ions for rapid SARS-CoV-2 inactivation
D. De Forni, B. Poddesu, … F. Lori·bioRxiv·Mar 11, 2021
- Discovery of Clioquinol and Analogues as Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, ACE2 and ACE2 - Spike Protein Interaction In Vitro
O. A. Olaleye, M. Kaur, … T. O. Adebusuyi·bioRxiv·Aug 14, 2020
- Chloroquine inhibits Zika Virus infection in different cellular models
Rodrigo Delvecchio, Luiza M Higa, … Amilcar Tanuri·bioRxiv·May 2, 2016
- Post-infection treatment with the E protein inhibitor BIT225 reduces disease severity and increases survival of k18-hACE2 transgenic mice infected with a lethal dose of SARS-CoV-2
Gary D. Ewart, Michael D. Bobardt, … Philippe A. Gallay·PLoS PathogensPeer-reviewed·Aug 7, 2023